Abstract
The current concept of the pathogenesis of obesity relates to the inflammation caused by excess of adipose tissue. Regulatory T cells accumulated in visceral adipose tissue (VAT-resident Tregs) are also involved in this pathogenesis. In the present paper the mechanisms responsible for alterations in the number and function of VAT-resident Tregs T in obesity are described. The role of Tregs in inflammation, insulin resistance, atherogenesis, and also the influence on VAT-resident Tregs of adipocytokines and insulin are reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson EK, Gutierrez DA, Hasty AH (2010) Adipose tissue recruitment of leukocytes. Curr Opin Lipidol 21:172–177
Chen X, Wu Y, Wang L (2013) Fat-resident Tregs: an emerging guard protecting from obesity-associated metabolic disorders. Obes Rev 14:568–578
Choi JH, Banks AS, Estall JL, Kajimura S, Boström P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Blüher M, Griffin PR, Spiegelman BM (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR-gamma by Cdk5. Nature 466(7305):451–456
Cipolletta D, Kolodin D, Benoist C, Mathis D (2011) Tissular T(regs): a unique population of adipose tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism. Semin Immunol 23(6):431–437
Conde J, Scotece M, Gomez R, Gómez-Reino JJ, Lago F, Gualillo O (2010) At the crossroad between immunity and metabolism: focus on leptin. Expert Rev Clin Immunol 6(5):801–808
Conde J, Scotece M, Abella V, Lopez V, Pino J, Gomez-Reino J, Gualillo O (2014) An update on leptin as immunomodulator. Expert Rev Clin Immunol 10(9):1165–1170
DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova JR, Markham D, Strissel KJ, Watkins AA, Zhu M, Allen J, Bouchard J, Toraldo G, Jasuja R, Obin MS, McDonnell ME, Apovian C, Denis GV, Nikolajczyk BS (2013) B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci 110(13):5133–5138 MEDIENCES
Deiuliis J, Shah Z, Shah N, Needleman B, Mikami D, Narula V, Perry K, Hazey J, Kampfrath T, Kollengode M, Sun Q, Satoskar AR, Lumeng C, Moffatt-Bruce S, Rajagopalan S (2011) Visceral adipose inflammation in obesity is associated with critical alterations in T regulatory cell numbers. PLoS One 6(1):e16376. doi:10.1371/journal.pone.0016376
de Jong A, Kloppenburg M, Toes RE, Joan-Facsinay A (2014) Fatty acids, lipid mediators, and T cell function. Front Immunol 5:483. doi:10.3389/fimmu.2014.00483
de Onis M, Blössner M, Borghi E (2010) Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 92(5):1257–1264
De Rosa V, Procaccini C, Cali G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G (2007) A key role of leptin in the control of regulatory T cell proliferation. Immunity 26:241–255
Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L, Takahashi H, Sun HW, Kanno Y, Powrie F, O’Shea JJ (2010) Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32(5):605–615
Eller K, Kirsch A, Wolf AM, Sopper S, Tagwerker A, Stanzl U, Wolf D, Patsch W, Rosenkranz AR, Eller P (2011) Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes 60(11):2954–2962
Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15:930–939
Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445
Han JM, Patterson SJ, Speck M, Ehses JA, Levings MK (2014) Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J Immunol 192:623–629
Ilan Y, Maron R, Tukpah AM, Maioli TU, Murugaiyan G, Yang K, Wu HY, Weiner HL (2010) Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci USA 107(21):9765–9770
Lolmède K, Duffaut C, Zakaroff-Girard A, Bouloumie A (2011) Immune cells in adipose tissue: key players in metabolic disorders. Diabetes Metab 37:283–290
Łuczynski W, Wawrusiewicz-Kurylonek N, Iłendo E, Bossowski A, Głowińska-Olszewska B, Krętowski A, Stasiak-Barmuta A (2012) Generation of functional T-regulatory cells in children with metabolic syndrome. Arch Immunol Ther Exp (Warsz) 60(6):487–495
Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121(6):2111–2117
Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1):175–184
Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, Bloom SR, Lechler RI, Zappacosta S, Fontana S (2001) Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 166(10):5909–5916
Matarese G, Procaccini C, De Rosa V, Horvath TL, La Cava A (2010a) Regulatory T cells in obesity: the leptin connection. Trends Mol Med 16:247–256
Matarese G, Carrieri PB, Montella S, De Rosa V, La Cava A (2010b) Leptin as a metabolic link to multiple sclerosis. Nat Rev Neurol 6(8):455–461
Moraes-Vieira PM, Larocca RA, Bassi EJ, Peron JP, Andrade-Oliveira V, Wasinski F, Araujo R, Thornley T, Quintana FJ, Basso AS, Strom TB, Camara NO (2014) Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur J Immunol 44(3):794–806
Nikolajczyk BS, Jagannathan-Bogdan M, Denis GV (2012) The outliers become a stampede as immunometabolism reaches a tipping point. Immunol Rev 249(1):253–275
Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11(2):85–97
Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T, Mantzoros C (2006) Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol 176(12):7745–7752
Pettersson US, Waldén TB, Carlsson PO, Jansson L, Phillipson M (2012) Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One 7(9):e46. doi:10.1371/journal.pone.0046057
Priceman SJ, Kujawski M, Shen S, Cherryholmes GA, Lee H, Zhang C, Kruper L, Mortimer J, Jove R, Riggs AD, Yu H (2013) Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci 110(32):13079–13084
Procaccini C, De Rosa V, Galgani M, Abanni L, Calì G, Porcellini A, Carbone F, Fontana S, Horvath TL, La Cava A, Matarese G (2010) An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33(6):929–941
Procaccini C, De Rosa V, Galgani M, Carbone F, Cassano S, Greco D, Qian K, Auvinen P, Calì G, Stallone G, Formisano L, La Cava A, Matarese G (2012) Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J Immunol 189:2941–2953
Sakaguchi S, Yamaguci T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133:775–787
Schipper HS, Prakken B, Kalkhoven E, Boes M (2012) Adipose tissue resident immune cells: key players in immunometabolism. Trends Endocrinol Metab 23:407–415
Taleb S, Herbin O, Ait-Oufella H, Verreth W, Gourdy P, Barateau V, Merval R, Esposito B, Clément K, Holvoet P, Tedgui A, Mallat Z (2007) Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 27:2691–2698
Taleb S, Tedgui A, Mallat Z (2008) Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med 263(5):489–499
Tian J, Dang HN, Yong J, Chui WS, Dizon MP, Yaw CK, Kaufman DL (2011) Oral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice. PLoS One 6(9):e25338. doi:10.1371/journal.pone.0025338
Wagner NM, Brandhors G, Czepluch F, Lankeit M, Eberle C, Herzberg S, Faustin V, Riggert J, Oellerich M, Hasenfuss G, Konstantinides S, Schafer K (2013) Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity 21:461–468
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796–1808
Winer S, Winer DA (2012) The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance. Immunol Cell Biol 90(8):755–762
Winer SY, Chan G, Paltser D, Truong H, Tsui J, Bahrami R, Dorfman Y, Wang J, Zielenski F, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D, Dosch HM (2009) Normalization of obesity associated insulin resistance through immunotherapy. Nat Med 15:921–929
Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H (2004) Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323(2):630–635
Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, Stephens JM, Mynatt RL, Dixit VD (2010) Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: Implications for systemic inflammation and insulin resistance. J Immunol 185(3):1836–1845
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kucharska, A.M., Pyrżak, B., Demkow, U. (2015). Regulatory T Cells in Obesity. In: Pokorski, M. (eds) Noncommunicable Diseases. Advances in Experimental Medicine and Biology(), vol 866. Springer, Cham. https://doi.org/10.1007/5584_2015_147
Download citation
DOI: https://doi.org/10.1007/5584_2015_147
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19973-3
Online ISBN: 978-3-319-19974-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)